Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.719
-0.018 (-2.49%)
At close: Apr 28, 2026, 4:00 PM EDT
0.720
+0.001 (0.11%)
Pre-market: Apr 29, 2026, 7:00 AM EDT
Genenta Science Employees
Genenta Science had 9 employees as of December 31, 2025. The number of employees decreased by 4 or -30.77% compared to the previous year.
Employees
9
Change (1Y)
-4
Growth (1Y)
-30.77%
Revenue / Employee
n/a
Profits / Employee
-$851,868
Market Cap
16.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9 | -4 | -30.77% |
| Dec 31, 2024 | 13 | -1 | -7.14% |
| Dec 31, 2023 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| SeaStar Medical Holding | 17 |
| IN8bio | 17 |
| Theriva Biologics | 16 |
| Lipocine | 14 |
| Pasithea Therapeutics | 5 |
| Cadrenal Therapeutics | 4 |
GNTA News
- 6 days ago - Genenta signs Definitive Agreements with Sophia High Tech - GlobeNewsWire
- 4 weeks ago - Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs - GlobeNewsWire
- 5 weeks ago - Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini - GlobeNewsWire
- 6 weeks ago - Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University - GlobeNewsWire
- 2 months ago - Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform - GlobeNewsWire
- 3 months ago - Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments - Benzinga
- 3 months ago - Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator - GlobeNewsWire
- 4 months ago - Genenta Science Provides Update on CEO Ownership - GlobeNewsWire